pharma is the sole category represented across all 1 tracked stories. KFF is most often covered alongside ABC News, which appears in 1 of these 1 story. We currently track 1 Biotech story that mention KFF, all published on July 29, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about KFF
pharma is the sole category represented across all 1 tracked stories. KFF is most often covered alongside ABC News, which appears in 1 of these 1 story. We currently track 1 Biotech story that mention KFF, all published on July 29, 2026. Each carries 2 original sources on average.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 3 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering KFF. Shared-story counts are live from our verified record — not editorial picks.
The termination of the $3.6 billion Part D premium subsidy could alter prescription utilization patterns for 25 million Medicare beneficiaries, potentially reducing demand for branded drugs and pressuring pharma companies reliant on Part D volume.